
Coronavirus and Cancer Resources for Survivors
Cancer survivors have expressed concerns and questions about COVID-19, the coronavirus, and how they may be at higher risk due to their cancer history. Here are some resources about COVID-19 generally, and its impact for cancer survivors specifically. NCCS is seeking answers from public health experts on the coronavirus and its impact on cancer patients and survivors. Please leave a comment [...]

JAMA Opinion Piece: The Short and Long Term Implications of Myriad Decision
On June 13, 2013, the Supreme Court ruled in Association for Molecular Pathology v. Myriad Genetics that a human gene removed from…

Jessie Gruman’s New York Times Blog Describes Patient’s Post-Discharge Experience
Jessie Gruman offers her fellow cancer survivors and their caregivers specific advice for improving the discussion that occurs between…

The Definition of “Cancer”: JAMA Opinion Piece Triggers Medical, Scientific, and Policy Debate
With the online publication of an opinion piece in the Journal of the American Medical Association, Drs. Laura J. Esserman, Ian M.…

NCCS Comments on Quality Measures for PPS-Exempt Cancer Hospitals
NCCS filed comments in support of proposed cancer care quality measures that will be utilized to assess the cancer care provided by…

Washington Post Wonkblog Discusses Myriad and BRCA Tests
The United States Supreme Court ruled unanimously on June 13, 2013, that human genes cannot be patented. In the case of Association…

Clinical Trials System Evaluation and IOM Workshop Summary
In the Sunday, July 14, New York Times, Clifton Leaf offered a critical evaluation of clinical trials. In letters to the editor published…

The ACA: Health Affairs Explains Upcoming Implementation and Exchanges
October 1, 2013 is rapidly approaching. That’s the beginning of open enrollment for insurance through state exchanges created to…

Clifton Leaf Opinion Piece in NY Times “Do Clinical Trials Work?”
Clifton Leaf, a cancer survivor and the author of "The Truth in Small Doses: Why We're Losing the War on Cancer - and How to Win It",…

NIH Appropriations: Senate Bill Includes an Increase in Funding Above FY 2013
The Senate Appropriations Committee approved a fiscal year 2014 funding bill by a party-line vote of 16 to 14 on July 11, 2013. In…

Shelley Fuld Nasso of NCCS Is Panelist at FDA Lung Cancer Meeting
Shelley Fuld Nasso, NCCS Senior Director of Policy, was a panelist at the June 28, 2013, Food and Drug Administration (FDA) meeting…